A multi-site evaluation of clinical pharmacist time, motion, interventions and interruptions
Martin L Canning1,2, Andrew Munns3, Jaryth Twine3
1Metro North Clinical Governance, Level 14, Block 7, Herston Health Campus, Herston, Qld, 4029, Australia. Martin.Canning@health.qld.gov.au.
Background:
Patient centred clinical pharmacy activities have demonstrated improvements in patient outcomes. There are limited published data on workflow practices of pharmacists to assist with clinical pharmacy service delivery improvement.
Aim:
To determine the amount of time clinical pharmacists spend each day performing their work tasks, interventions and interruptions. To determine the proportion of time performing clinical tasks and tasks face-to-face with patients.
Method:
Trained pharmacy students observed clinical pharmacists and recorded clinical activities using the timer app Clockify™ on a smart device (phone or tablet) at four hospitals over 9 days between 29th July and 8th August 2024. Pharmacy students recorded the number and types of patients seen, interventions and interruption patterns.
Results:
A total of 678.3 h of pharmacist activity were recorded. The mean time spent per day per patient type was 25.9 min (discharge patient), 23.5 min (new patient) and 10.3 min (review patient). Pharmacists spent the largest proportion of time (21.9%) on discharge patients followed by review patients (21.6%). Over 80% of pharmacist time was spent performing clinical activities, of which almost 12% was spent face-to-face with patients. Pharmacists were interrupted 34 times per day and performed 67 interventions per 100 patients.
Conclusion:
Pharmacists spend over 80% of their work time performing clinical activities for patients, of which almost 12% is spent face-to-face with patients. The largest proportion of time is spent with discharge patients followed by review patients.
More Related Videos
08:36Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
Published on: August 8, 2019
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Related Concept Videos
Methods of Documentation III: PIE
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Methods of Documentation II: POMR
Assessment of apical radial pulse
The A-R pulse assessment involves simultaneous evaluation of the apical and radial pulses. When the apical and radial pulse rates vary, this assessment helps identify a pulse deficit.
Pre-Procedural Preparation
